Income Statement (TTM)
JW (Cayman) Therapeutics Co. Ltd Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | -0 | -1 | 15 | 31 | 64 | 97 | 121 | 146 | 157 | 167 | 171 | 174 | 173 | 173 | 166 | 158 | 168 | 178 |
| Change (%) | -114.29 | 100.00 | -1,868.00 | 105.66 | 107.16 | 51.73 | 25.26 | 20.16 | 7.46 | 6.94 | 1.92 | 1.88 | -0.27 | -0.27 | -4.25 | -4.44 | 6.17 | 5.81 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 11 | 22 | 43 | 65 | 76 | 87 | 87 | 87 | 86 | 86 | 86 | 86 | 83 | 81 | 80 | 79 | |||
| Change (%) | 100.00 | 98.56 | 49.64 | 17.27 | 14.72 | 0.03 | 0.03 | -0.78 | -0.79 | 0.08 | 0.08 | -2.84 | -2.93 | -1.14 | -1.15 | ||||
| % of Revenue | 72.63 | 70.63 | 67.70 | 66.76 | 62.50 | 59.67 | 55.55 | 51.96 | 50.58 | 49.26 | 49.43 | 49.60 | 50.33 | 51.13 | 47.61 | 44.48 | |||
| Gross Operating Profit | 3 | -0 | -1 | 4 | 9 | 21 | 32 | 45 | 59 | 70 | 80 | 84 | 88 | 88 | 87 | 82 | 77 | 88 | 99 |
| Change (%) | -114.29 | 100.00 | -583.94 | 120.66 | 127.87 | 56.11 | 41.30 | 29.23 | 18.45 | 15.58 | 4.84 | 4.61 | -0.61 | -0.61 | -5.64 | -5.98 | 13.82 | 12.14 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 27.37 | 29.37 | 32.30 | 33.24 | 37.50 | 40.33 | 44.45 | 48.04 | 49.42 | 50.74 | 50.57 | 50.40 | 49.67 | 48.87 | 52.39 | 55.52 |
| SG&A | 186 | 280 | 315 | 344 | 372 | 384 | 396 | 383 | 371 | 352 | 334 | 294 | 253 | 252 | 250 | 255 | 260 | 238 | 216 |
| Change (%) | 50.01 | 12.56 | 9.12 | 8.36 | 3.24 | 3.13 | -3.24 | -3.35 | -4.92 | -5.18 | -12.10 | -13.77 | -0.68 | -0.69 | 2.14 | 2.10 | -8.58 | -9.39 | |
| % of Revenue | 6,290.57 | -66,044.16 | -37,170.25 | 2,294.10 | 1,208.72 | 602.34 | 409.43 | 316.27 | 254.38 | 225.07 | 199.56 | 172.10 | 145.66 | 145.05 | 144.44 | 154.09 | 164.63 | 141.75 | 121.38 |
| R&D | 195 | 277 | 328 | 371 | 414 | 420 | 425 | 416 | 408 | 418 | 428 | 421 | 414 | 381 | 348 | 316 | 283 | 254 | 224 |
| Change (%) | 42.21 | 18.65 | 13.08 | 11.57 | 1.25 | 1.24 | -2.00 | -2.04 | 2.53 | 2.47 | -1.73 | -1.76 | -7.92 | -8.60 | -9.35 | -10.32 | -10.42 | -11.63 | |
| % of Revenue | 6,567.68 | -65,368.71 | -38,778.98 | 2,480.32 | 1,345.58 | 657.65 | 438.80 | 343.33 | 279.90 | 267.07 | 255.90 | 246.73 | 237.91 | 219.65 | 201.29 | 190.57 | 178.86 | 150.91 | 126.03 |
| OpEx | 380 | 553 | 638 | 720 | 803 | 839 | 876 | 860 | 843 | 838 | 832 | 788 | 744 | 710 | 675 | 646 | 617 | 564 | 510 |
| Change (%) | 45.41 | 15.36 | 12.92 | 11.44 | 4.60 | 4.39 | -1.91 | -1.94 | -0.63 | -0.63 | -5.30 | -5.60 | -4.63 | -4.86 | -4.28 | -4.47 | -8.66 | -9.48 | |
| % of Revenue | 12,825.91 | -130,527.74 | -75,290.44 | 4,808.76 | 2,605.82 | 1,315.65 | 905.20 | 708.91 | 578.49 | 534.96 | 497.07 | 461.85 | 427.94 | 409.20 | 390.36 | 390.25 | 390.13 | 335.62 | 287.09 |
| Operating Income | -377 | -553 | -639 | -705 | -772 | -776 | -779 | -738 | -697 | -681 | -665 | -617 | -570 | -536 | -502 | -481 | -459 | -396 | -333 |
| Change (%) | 46.66 | 15.43 | 10.43 | 9.44 | 0.50 | 0.50 | -5.28 | -5.57 | -2.32 | -2.37 | -7.12 | -7.67 | -5.96 | -6.34 | -4.29 | -4.48 | -13.78 | -15.98 | |
| % of Revenue | -12,725.91 | 130,627.74 | 75,390.44 | -4,708.76 | -2,505.82 | -1,215.65 | -805.20 | -608.91 | -478.49 | -434.96 | -397.07 | -361.85 | -327.94 | -309.20 | -290.36 | -290.25 | -290.13 | -235.62 | -187.09 |
| Interest Expense | -1 | -1 | -1 | -2 | -3 | -4 | -5 | -6 | -7 | -8 | -10 | -11 | -12 | -13 | -13 | -13 | -12 | -12 | -12 |
| Change (%) | 17.03 | 13.82 | 82.35 | 45.16 | 40.16 | 28.65 | 19.91 | 16.61 | 21.25 | 17.52 | 14.19 | 12.42 | 1.89 | 1.86 | -2.58 | -2.65 | 0.79 | 0.78 | |
| % of Revenue | -25.76 | 210.98 | 120.07 | -12.38 | -8.74 | -5.91 | -5.01 | -4.80 | -4.66 | -5.26 | -5.78 | -6.47 | -7.14 | -7.30 | -7.45 | -7.58 | -7.72 | -7.33 | -6.98 |
| Net Income | -1,295 | -1,479 | -1,294 | -998 | -702 | -777 | -851 | -849 | -846 | -822 | -797 | -783 | -768 | -698 | -628 | -609 | -591 | -604 | -618 |
| Change (%) | 14.25 | -12.48 | -22.87 | -29.65 | 10.58 | 9.56 | -0.28 | -0.28 | -2.89 | -2.97 | -1.84 | -1.87 | -9.12 | -10.04 | -2.96 | -3.05 | 2.29 | 2.23 | |
| % of Revenue | -43,677.80 | 349,264.70 | 152,829.87 | -6,667.10 | -2,280.51 | -1,217.24 | -878.98 | -699.79 | -580.73 | -524.83 | -476.18 | -458.64 | -441.74 | -402.51 | -363.06 | -367.95 | -373.30 | -359.63 | -347.47 |
Source: Capital IQ
